Study in Parkinson's Disease of Exercise
Status: | Completed |
---|---|
Conditions: | Parkinsons Disease |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 40 - 80 |
Updated: | 10/15/2017 |
Start Date: | May 2012 |
End Date: | November 2016 |
Exploratory Study of Different Doses of Endurance Exercise in People With Parkinson Disease
The purpose of this study is to learn more about the effects of exercise on patients who have
been recently diagnosed with Parkinson's disease (PD). The investigators are going to test
two levels of exercise (moderate to vigorous) against no exercise. The investigators think
that exercise may reduce the symptoms the of PD, and the investigators hope to learn what
level of exercise will offer the most benefit.
been recently diagnosed with Parkinson's disease (PD). The investigators are going to test
two levels of exercise (moderate to vigorous) against no exercise. The investigators think
that exercise may reduce the symptoms the of PD, and the investigators hope to learn what
level of exercise will offer the most benefit.
The overall objective of this study is to determine the futility or non-futility of
conducting a randomized controlled trial to determine the effects of exercise on the
progression of PD symptoms. The primary aim is to determine whether individuals with de novo
Parkinson's disease (naïve to drug treatment) can achieve the randomly assigned levels of
mean exercise intensity (60-65% HRmax or 80-85% HRmax) and adhere to the exercise protocol.
conducting a randomized controlled trial to determine the effects of exercise on the
progression of PD symptoms. The primary aim is to determine whether individuals with de novo
Parkinson's disease (naïve to drug treatment) can achieve the randomly assigned levels of
mean exercise intensity (60-65% HRmax or 80-85% HRmax) and adhere to the exercise protocol.
Inclusion Criteria:
- Clinical diagnosis of primary Parkinson's disease
- In a Hoehn and Yahr stage less than stage III
- Disease duration is less than 5 years
- Not likely to require dopaminergic therapy within 6 months
Exclusion Criteria:
- Use of any PD medication within 60 days prior to the beginning the study, including
levodopa, direct dopamine agonists, amantadine, Rasagiline (Azilect), Selegiline
(Eldepryl), Artane (trihexyphenidyl).
- Duration of previous use of medications for PD that exceeds 90 days
- Expected to require dopaminergic therapy in the next 6 months
- Poorly controlled or unstable cardiovascular disease
- Uncontrolled hypertension
- Hypo- or hyperthyroidism, abnormal liver function, abnormal renal function
- Mild cognitive impairment (Montreal Cognitive Assessment score<26/30)
- Depression that precludes ability to exercise (Beck depression score>13)
- Disorders that interfere with ability to perform endurance exercises
- Regular participation in vigorous endurance exercise
- Evidence of serious arrhythmias or ischemic heart disease
- Any clinically significant medical condition, psychiatric condition, drug or alcohol
abuse, or laboratory abnormality that would, in the judgment of the investigators,
interfere with the ability to participate in the study
We found this trial at
3
sites
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
Click here to add this to my saved trials
University of Colorado Denver The University of Colorado Denver | Anschutz Medical Campus provides a...
Click here to add this to my saved trials
University of Illinois at Chicago A major research university in the heart of one of...
Click here to add this to my saved trials